
Exelis Inc. - Wikipedia
Exelis Inc., was a global aerospace, defense, information and services company [2] created in October 2011 as a result of the spinoff of ITT Corporation's defense business into an …
Shaping the Future of Oncology for Patients l Exelixis
Mar 26, 2025 · At Exelixis, cancer is our cause. Over the course of the past three decades, we’ve evolved into a multi-platform cancer company dedicated to creating treatment regimens that …
Harris Corp. To Acquire Exelis for $4.75 Billion - SpaceNews
Feb 6, 2015 · WASHINGTON — Harris Corp.’s planned $4.75 billion acquisition of Exelis Corp., announced Feb. 6, will combine a host of related space capabilities that appear largely …
Harris buying defense contractor Exelis in $4.4 deal | AP News
Exelis, the former defense unit of manufacturer ITT Corp., makes night-vision goggles, anti-bomb products and does technical work for the government. Harris Chairman, President and CEO …
Exelixis, Inc. (EXEL) Stock Price, News, Quote & History - Yahoo Finance
Find the latest Exelixis, Inc. (EXEL) stock quote, history, news and other vital information to help you with your stock trading and investing.
Harris Corporation Completes Acquisition of Exelis
MELBOURNE, Fla., May 29, 2015 – Harris Corporation (NYSE:HRS) today completed its previously announced acquisition of Exelis Inc. (NYSE:XLS). Each outstanding share of Exelis …
Exelis - Company Profile on everything RF
Exelis Inc. is a spinoff of ITT Corporation''s defense business into an independent, publicly traded company in October 2011. They are an aerospace, defense, information services …
Exelis Inc - Company Profile and News - Bloomberg Markets
Exelis Inc. is a diversified, global aerospace, defense and information solutions company.
Harris Corporation to Buy Defense Contractor Exelis for $4.7 …
Feb 6, 2015 · The Harris Corporation, which makes satellite and other communications equipment for businesses and governments, said on Friday that it had agreed to acquire Exelis for $4.7 …
Evolving How Cancer is Treated l Exelixis
As a leading cause of death worldwide, cancer accounts for almost 10 million deaths annually. 1,2 We are leveraging innovations in oncology drug development to expand our horizons for what …
- Some results have been removed